Davis Polk advised Track & Field Co S.A. and the selling shareholders in connection with Track & Field’s initial public offering of 49,166,000 preferred shares for an aggregate…
Davis Polk advised the representatives of the several underwriters in connection with Abcam plc’s $180 million U.S. initial public offering of 10,287,000 American depositary shares…
Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation of …
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €1.75 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2029. …
Davis Polk advised the sole book runner in connection with the initial public offering of 12,500,000 units of Yellowstone Acquisition Company for aggregate proceeds of $125 million…
Davis Polk advised the representative of the initial purchasers in connection with concurrent Rule 144A/Regulation S offerings by Ligado Networks LLC of $2.85 billion aggregate principal…
Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.
Xspray was founded in 2003…
Davis Polk advised Banco Votorantim S.A. in connection with the offering of $100 million aggregate principal amount of its 4.375% global medium-term notes due 2025 under its global medium…
Davis Polk advised the underwriters in connection with the $200 million initial public offering of 20,000,000 units of Decarbonization Plus Acquisition Corporation. Each unit consists…
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of €450 million aggregate principal amount of senior notes due…